What is Picodya?
Founded in 2018 and headquartered in Rehovot, Israel, Picodya is a developer of an in vitro diagnostics platform designed for widespread deployment at the point of care. Their technology is suitable for diverse settings, ranging from intensive care units and hospital departments to field hospitals, clinics, and home care environments, addressing a critical need for accessible and immediate diagnostic solutions.
How much funding has Picodya raised?
Picodya has raised a total of $10M across 1 funding round:
Unspecified
$10M
Unspecified (2020): $10M with participation from SIBF
Key Investors in Picodya
SIBF
SIBF is an investor participating in the funding round, with their specific focus area not detailed.
What's next for Picodya?
The recent major strategic investment signals a pivotal growth phase for Picodya. This substantial backing is expected to accelerate the company's product development, market penetration, and scaling of operations. With a focus on enterprise-level funding, Picodya is positioning itself for significant expansion and aims to solidify its market presence in the rapidly evolving diagnostics industry.
See full Picodya company page
